Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking
Chiara Vantaggiato, Elena Panzeri, Andrea Citterio, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 3, pp. 189-210
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma
Yaogang Zhong, Feng Geng, Logan Mazik, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101706-101706
Open Access | Times Cited: 8
A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons
Sergio Espeso‐Gil, Tobias Halene, Jaroslav Bendl, et al.
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Olanzapine, risperidone and ziprasidone differently affect lysosomal function and autophagy, reflecting their different metabolic risk in patients
Marco Pozzi, Chiara Vantaggiato, F Brivio, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Antipsychotic-Induced Alterations in Lipid Turnover
Sandra Pereira, Emily Au, Sri Mahavir Agarwal, et al.
Endocrinology (2023) Vol. 164, Iss. 4
Open Access | Times Cited: 11
Unraveling antipsychotic induced weight gain in schizophrenia – a proof-of-concept study exploring the impact of the cumulative historical occupancy of different receptors by antipsychotics
F Sudár, Samar Samy Zekerallah, Michael Paulzen, et al.
Psychiatry Research (2025), pp. 116452-116452
Closed Access
The synthetic TRPML1 agonist ML-SA1 mitigates intracellular lipid accumulation induced by antipsychotics in vitro by stimulating release of extracellular microvesicles
Irene Chavarría-Cubel, Yessenia L. Molina, Bohdan Babiy, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2025), pp. 159611-159611
Closed Access
A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and psychopathology
Marco Pozzi, Faizan Mazhar, Gabriëlla G. A. M. Peeters, et al.
Journal of Affective Disorders (2019) Vol. 257, pp. 774-778
Closed Access | Times Cited: 32
Epigenetic histone modulations of PPARγ and related pathways contribute to olanzapine-induced metabolic disorders
Yueqing Su, Xuemei Liu, Jiamei Lian, et al.
Pharmacological Research (2020) Vol. 155, pp. 104703-104703
Closed Access | Times Cited: 32
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model
Kateřina Horská, Silje Skrede, Jan Kučera, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 3
Effect of antipsychotics and mood stabilisers on metabolism in bipolar disorder: a network meta-analysis of randomised-controlled trials
Lingzhuo Kong, Huaizhi Wang, Ning Yan, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102581-102581
Open Access | Times Cited: 3
Early signs of neurodegenerative diseases: Possible mechanisms and targets for Golgi stress
Mengyu Liu, Ying Duan, Jianru Dong, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116646-116646
Open Access | Times Cited: 3
Psychotomimetic compensation versus sensitization
Ari Brouwer, Robin Carhart‐Harris, Charles L. Raison
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 3
Recombinant human lactoferrin attenuates the progression of hepatosteatosis and hepatocellular death by regulating iron and lipid homeostasis in ob/ob mice
Chuang Guo, Xue Han, Tian Guo, et al.
Food & Function (2020) Vol. 11, Iss. 8, pp. 7183-7196
Closed Access | Times Cited: 26
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
Carla Carnovale, Vera Battini, Claudia Santoro, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2023) Vol. 63, Iss. 3, pp. 313-335
Open Access | Times Cited: 8
Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice
Megan Beauchemin, Ramaz Geguchadze, Anyonya R. Guntur, et al.
Pharmacological Research (2019) Vol. 152, pp. 104589-104589
Open Access | Times Cited: 24
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: a network meta-analysis and regression
Carla Carnovale, Ersilia Lucenteforte, Vera Battini, et al.
Psychological Medicine (2021) Vol. 52, Iss. 15, pp. 3508-3520
Closed Access | Times Cited: 20
Impaired mitophagosome–lysosome fusion mediates olanzapine‐induced aging
Xi Chen, Zhizhen Wang, Peng Zheng, et al.
Aging Cell (2023) Vol. 22, Iss. 11
Open Access | Times Cited: 6
Hydroxytyrosol Plays Antiatherosclerotic Effects through Regulating Lipid Metabolism via Inhibiting the p38 Signal Pathway
Xinxin Zhang, Yating Qin, Xiaoning Wan, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 15
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation
Kateřina Horská, Hana Kotolová, Michal Karpíšek, et al.
Toxicology and Applied Pharmacology (2020) Vol. 406, pp. 115214-115214
Closed Access | Times Cited: 15
Long-term administration of low-dose selenium nanoparticles with different sizes aggravated atherosclerotic lesions and exhibited toxicity in apolipoprotein E-deficient mice
Junying Xiao, Hui Cao, Siyu Guo, et al.
Chemico-Biological Interactions (2021) Vol. 347, pp. 109601-109601
Closed Access | Times Cited: 14
Lipid‐correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia
Wataru Arihisa, Takeshi Kondo, Katsushi Yamaguchi, et al.
Neuropsychopharmacology Reports (2023) Vol. 43, Iss. 3, pp. 403-413
Open Access | Times Cited: 5
Metabolomics, Lipidomics, and Antipsychotics: A Systematic Review
Kyle J. Burghardt, Megan Kajy, Kristen M. Ward, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3295-3295
Open Access | Times Cited: 5
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue
Jan Kučera, Kateřina Horská, Pavel Hruška, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 108, pp. 110165-110165
Closed Access | Times Cited: 14
The Antipsychotic Risperidone Alters Dihydroceramide and Ceramide Composition and Plasma Membrane Function in Leukocytes In Vitro and In Vivo
Alberto Canfrán‐Duque, Óscar Pastor, David García‐Seisdedos, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3919-3919
Open Access | Times Cited: 12
Biological Behavior and Lipid Metabolism of Colon Cancer Cells are Regulated by a Combination of Sterol Regulatory Element-Binding Protein 1 and ATP Citrate Lyase
Zhendong Qiu, Wenhong Deng, Yu-pu Hong, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 1531-1542
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top